Media

January 13, 2025: ARES Trial of MaaT013 in Acute GVHD Meets Primary End Point – Targeted Oncology

Date : January 27, 2025

To see the interview click here

January 10, 2025: MaaT013 Elicits Durable Responses in Acute Graft-vs-Host Disease – Cancer Network

January 13, 2025: Microbiote : résultats positifs d’une étude clinique – Ouest France (French Only)